Evidence map›Paper›PMID 26438293›Full record

ArticleG3 (Bethesda, Md.)2015

Markerless Escherichia coli rrn Deletion Strains for Genetic Determination of Ribosomal Binding Sites.

Selwyn Quan, Ole Skovgaard, Robert E McLaughlin, Ed T Buurman, Catherine L Squires

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Community interactions drive the evolution of antibiotic tolerance in bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Selwyn QuanDepartment of Biology, Stanford University, Stanford, California 094305.
Ole SkovgaardDepartment of Science, Systems and Models, Roskilde University, DK-4000 Roskilde, Denmark.ORCID http://orcid.org/0000-0002-4860-1847
Robert E McLaughlinDepartment of Biosciences, Infection Innovative Medicines Unit, AstraZeneca R&D Boston, Waltham, Massachusetts 02451.
Ed T BuurmanDepartment of Biosciences, Infection Innovative Medicines Unit, AstraZeneca R&D Boston, Waltham, Massachusetts 02451 Ed.Buurman@pfizer.com.
Catherine L SquiresDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111.
Stanford University · USAstraZeneca (United States) · USRoskilde University · DKTufts University · US

Funding

FUSION OF THE RIBOSOMAL RNA PROMOTER TO OTHER OPERONSR01GM024751 · NIGMS · TUFTS UNIVERSITY BOSTON · PI SQUIRES, CATHERINE L · 1985 to 2007
$4.0M
NIGMS NIH HHS R01 GM024751NIGMS NIH HHS R01-GM24751
6 · The paper itself

Abstract

Single-copy rrn strains facilitate genetic ribosomal studies in Escherichia coli. Consecutive markerless deletion of rrn operons resulted in slower growth upon inactivation of the fourth copy, which was reversed by supplying transfer RNA genes encoded in rrn operons in trans. Removal of the sixth, penultimate rrn copy led to a reduced growth rate due to limited rrn gene dosage. Whole-genome sequencing of variants of single-copy rrn strains revealed duplications of large stretches of genomic DNA. The combination of selective pressure, resulting from the decreased growth rate, and the six identical remaining scar sequences, facilitating homologous recombination events, presumably leads to elevated genomic instability.

Indexed as

Binding SitesOperonSequence DeletionAnti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliRibosomesRNA, RibosomalRNA, TransferAnti-Bacterial AgentsRNA, RibosomalRNA, Transferduplicationgenomic instabilityribosomerrlrrs

Identifiers

PMID26438293
PMCPMC4683628
OpenAlexW2222228083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.